-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IZ68UMLedaADlK89+ndfgz1tA5dWlerPvTpJ4R3qIcKccIYf5SsZyEayQcHpP2qb To+ODOUpFug9UZg0OFj1Gw== 0001047469-99-031342.txt : 19990813 0001047469-99-031342.hdr.sgml : 19990813 ACCESSION NUMBER: 0001047469-99-031342 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990812 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ CENTRAL INDEX KEY: 0000918112 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943049219 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-49135 FILM NUMBER: 99685261 BUSINESS ADDRESS: STREET 1: 1387 MARINA WAY S CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5102158000 MAIL ADDRESS: STREET 1: 1387 MARINA WAY SOUTH CITY: RICHMOND STATE: CA ZIP: 94804 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MERZ PLUS CO GMBH & CO CENTRAL INDEX KEY: 0001092702 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: I8 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ECKENHEIMER LANDSTRASSE 100-104 CITY: FRANKFURT AM GERMANY BUSINESS PHONE: 011496915030 MAIL ADDRESS: STREET 1: ECKENHEIMER LANDSTRASSE 100-104 CITY: FRANKFURT AM GERMANY SC 13G 1 SC 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ----------------------- SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) and (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (Amendment No. ________________)1 NEUROBIOLOGICAL TECHNOLOGIES, INC. ------------------------------------------------------- (Name of Issuer) COMMON STOCK , PAR VALUE $0.001 PER SHARE ------------------------------------------------------- (Title of Class of Securities) 00064124W1 ------------------------------------------------------- (CUSIP Number) AUGUST 3, 1999 ------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) / X / Rule 13d-1(c) / / Rule 13d-1(d) - ------------------- 1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - ---------------------------------------- ----------------------------------- CUSIP No. 00064124W1 13G Page 2 of 5 Pages - ---------------------------------------- ----------------------------------- - ---------- ---------------------------------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON IRS IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) MERZ + CO. GMBH & CO. NONE - ---------- ---------------------------------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) / / - ---------- ---------------------------------------------------------------------------------------------------------- 3. SEC USE ONLY - ---------- ---------------------------------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION GERMANY - ---------------------------- ----------------- ---------------------------------- ----------------------------------- Number of Shares 5. SOLE VOTING POWER 650,419 Beneficially Owned By Each Reporting Person With ----------------- ---------------------------------- ----------------------------------- 6. SHARED VOTING POWER NIL ----------------- ---------------------------------- ----------------------------------- 7. SOLE DISPOSITIVE POWER 650,419 ----------------- ---------------------------------- ----------------------------------- 8. SHARED DISPOSITIVE POWER NIL - ---------- ---------------------------------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 650,419 - ---------- ---------------------------------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / - ---------- ---------------------------------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.2% - ---------- ---------------------------------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* 00 - ---------- ---------------------------------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 3 of 5 ITEM 1(a). NAME OF ISSUER Neurobiological Technologies, Inc. ITEM 1(b). ADDRESS OF ISSUERS' PRINCIPAL EXECUTIVE OFFICES 1387 Marina Way South Richmond, California 94804 ITEM 2(a). NAME OF PERSONS FILING Merz + Co. GmbH & Co. ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE Eckenheimer Landstrasse 100-104 60318 Frankfurt a.M. Germany ITEM 2(c). CITIZENSHIP Germany ITEM 2(d). TITLE OF CLASS OF SECURITIES Common Stock ITEM 2(e). CUSIP NUMBER 00064124W1 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR 2(c), CHECK WHETHER THE PERSON FILING IS A N.A. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(c), CHECK THIS BOX. / X / ITEM 4. OWNERSHIP (a) Amount Beneficially Owned: Immediately exercisable right to convert loans, including interest thereon, into 650,419 shares of Common Stock (b) Percent of Class: 6.2% (assumes exercise of conversion rights) (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 650,419 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 650,419 (iv) shared power to dispose or to direct the disposition of: 0 Page 4 of 5 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS N.A. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON N.A. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY N.A. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP N.A. ITEM 9. NOTICE OF DISSOLUTION OF GROUP N.A. ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities, and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 5 of 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: August 9, 1999 Merz + Co. GmbH & Co. /s/ Dr. Peter Mauritz -------------------------------------- By: Dr. Peter Mauritz Its: /s/ H. W. GLAAB -------------------------------------- By: H. W. GLAAB Its:
-----END PRIVACY-ENHANCED MESSAGE-----